The National Technical Advisory Group on Immunisation (NTAGI) which reviewed the data of Corbevax earlier had found significant antibody re...

The COVID-19 Working Group of the National Technical Advisory Group on Immunisation (NTAGI) made the recommendation in its 48th meeting hel...

The WHO website states that the rolling data submission has begun on June 10 and the decision date on EUL is yet to be confirmed. The compa...

The experts will review its data for its use as a standalone vaccine and will also weigh its benefits as a booster shot and take a decision...

The Corbevax vaccine has been recommended for 5-12 years old, meanwhile, Covaxin will be used for children aged 6-12 years.

"We will review the data of Corbevax in our next meeting slated to happen this month and evaluate if mix and match of vaccines can be allow...

The NTAGI's Standing Technical Sub-Committee (STSC), which met on Thursday, also reviewed the findings of a study by the Christian Medical ...

India's drug regulator on Saturday granted approval to Hyderabad-based Biological E's Covid-19 vaccine Corbevax to be allowed as a booster ...

The vaccine can be administered after 6 months of administration of primary vaccination (two doses) of Covaxin or Covishield vaccines for r...

The Drugs Controller General Of India (DCGI) had already approved Corbevax, India's first indigenously developed RBD protein subunit vaccin...

"It is necessary to quickly initiate the process of recognition of the Corbevax vaccine and its certificate by other countries while Biolog...

Prime Minister Narendra Modi in an interaction with chief ministers on Wednesday had said that the government's priority is to vaccinate al...

"The states have started receiving the Corbevax doses, but no decision has yet been taken regarding its use, as of now," people in the gove...

The company's shot, called Corbevax, is the third vaccine approved for use in children aged 12 and above in India, joining Zydus Cadila's D...

The pandemic is not over. There is a need to ensure universal vaccination at home and abroad. India needs to move quickly on its domestic r...

The subject experts committee (SEC), a body under India's drug regulator, will meet on Monday to review the applications for granting appro...

Currently, phase 2/3 clinical trials of the second indigenously developed Corbevax, an RBD protein sub-unit vaccine to be administered in a...